postoperative residual pain after vertebroplasty for osteoporotic vertebral compression fractures
Conditions
Interventions
FSN therapy group:Fu’s Subcutaneous Needling (Treatment once a day, a total of 7 treatments)+ Meloxicam tablets
Control Group:Meloxicam tablets, 7.5mg(1 tablet) once daily
Sponsors
Suining Central Hospital
Eligibility
Sex/Gender
All
Age
50 Years to No maximum
Inclusion criteria
Inclusion criteria: (1) Meets the diagnostic criteria for osteoporotic vertebral compression fractures in the Expert Consensus on the Diagnosis and Treatment of osteoporotic vertebral compression Fractures (2021 edition); (2) Aged 50 years and over; (3) VAS score >= 4 points; (4) Lower back pain was still present, 24 hours after percutaneous vertebroplasty (PVP)/percutaneous kyphoplasty (PKP); (5) Palpation of soft tissues in the low back was "tight, stiff, hard and slippery", accompanied by local pain; (6) Volunteer to participate in this study and sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with other injuries or fractures to the lower back, prior spinal surgery, or spinal malformations. (2) Patients with metastatic tumor, spinal infection,metabolic bone disease, including primary parathyroid hormone bone disease, renal bone disease, toxic bone disease; (3) Combined with other chronic diseases or other neurological disorders that cause low back pain; (4) Patients with uneven distribution of bone cement, bone cement leakage and multiple vertebral fractures after PVP/PKP; (5) Patients with severe back skin injury, postoperative incision swelling, exudation, and bleeding tendency; (6) Serious cardiovascular and cerebrovascular diseases, digestive system diseases, liver and kidney function abnormalities, and blood system diseases; (7) Suffer from mental and psychosomatic diseases, such as anxiety and depression; (8) Those with poor compliance do not want to participate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain;Temperature at the site of pain; | — |
Secondary
| Measure | Time frame |
|---|---|
| Oswestry;Japanese Orthopaedic Association(JOA);Levels of serum inflammatory factors; | — |
Countries
China
Contacts
Public ContactWang Qiong
Suining Central Hospital
Outcome results
None listed